Oruka Therapeutics, Inc. (ORKA)

SEC filing

Oruka Therapeutics, Inc.

ORKA · CIK 907654

4 · Sep 1, 2026 · Chief Operating Officer Sandler Laura Lee sold 5,000 shares at $91.82/share ($459.1K); exercised options for 10K shares

Chief Operating Officer Sandler Laura Lee sold 5,000 shares at $91.82/share ($459.1K); exercised options for 10K shares

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

xslF345X06/form4.xmlSEC.gov

Graphics and non-inline formats (not embedded below).

4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESform4.xml
Open SEC.gov